D-dimer levels and outcomes in heart failure with mildly reduced ejection fraction
Finn Kronberg1, Tobias Schupp1, Michael Behnes1
1Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Germany.
Insights
Elevated D-dimer levels indicate a worse prognosis for patients hospitalized with heart failure with mildly reduced ejection fraction (HFmrEF). Higher D-dimer levels are independently linked to an increased risk of all-cause mortality in these patients.
Area of Science:
- Cardiology
- Internal Medicine
- Biomarkers
Background:
- Prognostic impact of D-dimer levels in heart failure with mildly reduced ejection fraction (HFmrEF) remains understudied.
- HFmrEF affects a significant patient population, necessitating better prognostic tools.
Purpose of the Study:
- To investigate the association between D-dimer levels and prognosis in hospitalized patients with HFmrEF.
- To determine if D-dimer levels can predict all-cause mortality and heart failure rehospitalization in this cohort.
Main Methods:
- Retrospective analysis of 1126 HFmrEF patients from 2016-2022.
- Patients categorized into quartiles based on D-dimer levels.
- Primary endpoint: 30-month all-cause mortality; secondary endpoint: HF-related rehospitalization.
Main Results:
- Higher D-dimer levels correlated with increased all-cause mortality risk (Q4 vs. Q1: aHR 3.228).
- This association remained significant after multivariable adjustment and exclusion of patients with conditions causing elevated D-dimer.
- Median D-dimer level was 0.87 µg/mL.
Conclusions:
- Elevated D-dimer levels are an independent predictor of mortality in HFmrEF patients.
- D-dimer may serve as a valuable prognostic biomarker in HFmrEF management.
Objective:
The study investigates the influence of D-dimer levels on the prognosis of patients hospitalized with heart failure with mildly reduced ejection fraction (HFmrEF).
Background:
The prognostic impact of D-dimer levels has not yet been investigated in patients with HFmrEF.
Methods:
We retrospectively included consecutive patients with HFmrEF at one institution from 2016 to 2022. Patients were divided in quartiles according to their D-dimer levels, further sub-analyses were performed after excluding patients with conditions associated with increased D-dimer levels. The primary endpoint was all-cause mortality at 30 months (median follow-up), key secondary endpoint was the risk of heart failure (HF)-related rehospitalization.
Results:
In total, 1126 patients with HFmrEF were included with a median D-dimer level of 0.87 µg/mL (interquartile range 0.42-2.19 µg/mL). Higher D-dimer levels were associated with an increased risk of all-cause mortality (Q4 vs. Q1: hazard ratio (HR) 6.817; 95% confidence interval (95% CI) 4.401-10.561, p = 0.001), which was still observed after multivariable adjustment (Q4 vs. Q1: adjusted (a)HR 3.228; 95% CI 1.901-5.479; p = 0.001). This association was still observed after excluding patients with conditions associated with elevated D-dimer levels.
Conclusion:
Elevated D-dimer levels were independently associated with a higher risk of all-cause mortality in HFmrEF patients.
More Related Videos
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
